Two case reports of skin vasculitis following the COVID-19 immunization

Anželika Chomičienė; Kęstutis Černiauskas; Kotryna Linauskienė; Raimundas Meškauskas; Laura Malinauskienė

doi:10.1515/med-2022-0608

Two case reports of skin vasculitis following the COVID-19 immunization

Open Med (Wars). 2022 Dec 9;17(1):1944-1948. doi: 10.1515/med-2022-0608. eCollection 2022.

Authors

Anželika Chomičienė¹, Kęstutis Černiauskas¹, Kotryna Linauskienė^{1

2}, Raimundas Meškauskas³, Laura Malinauskienė¹

Affiliations

¹ Vilnius University, Medical Faculty, Institute of Clinical Medicine, Clinic of Chest Diseases, Immunology and Allergology, Department of Pulmonology and Allergology, Vilnius, Lithuania.
² Vilnius University Hospital Santaros Klinikos, Department of Pulmonology and Allergology, Santariškių Str. 2, Vilnius LT-08661, Lithuania.
³ Pathology Department, National Center of Pathology, Affiliate of Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

Abstract

The coronavirus 2019 (COVID-19) disease is now responsible for one of the most challenging and concerning pandemics. Since December 2020, the world has had access to COVID-19 prophylaxis; thus, we encounter adverse events from vaccination more often due to the vast vaccination range. We present two case reports of difficult-to-treat skin vasculitis due to COVID-19 vaccination that were successfully treated in a tertiary-level university hospital. When encountering systemic treatment, resistant skin vasculitis plasmapheresis could be a choice of treatment.

Keywords: COVID-19 disease; adverse events; case report; mRNA vaccine; plasmapheresis; vaccine; vasculitis.

Publication types

Case Reports